Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML

Clinical trial NCT05584761 · RECRUITING

Trial details

NCT number: NCT05584761
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia-2 Secondary Acute Myeloid Leukemia

Start date: 2022-03-01
Primary completion: 2026-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.